With the help of single-cell analysis, researchers have shown that although transplant sarcomas can be treated by programmed cell death-1 (PD-1) blockade and radiotherapy, this treatment cannot cure autochthonous tumors. This evidence concerns the gene PDCD1 and sarcoma.